First-time oral bisphosphonate users are at higher risk for developing uveitis and scleritis.
The FDA has granted Apotex Inc., Orchid Healthcare and Mylan Pharmaceuticals approval to market 150 mg generic ibandronate tablets.
An implantable microchip about the size of a flash memory drive that can be controlled remotely, delivered doses of an osteoporosis drug with the same efficacy as injection.
Osteoporosis affects approximately 10 million Americans, and another 40 million are at risk for the bone disorder. One in two women and one in four men age 50 years and older will experience an osteoporosis-related fracture in their lifetime, with estimated health-care costs totaling approximately $14 billion each year. These numbers are expected to increase…
Treating patients before they develop a disease is tempting, but the old
adage still applies: First, do no harm.
Is it safe to restart osteoporosis medications in patients with stage 5 chronic kidney disease?
Inappropriate screening could lead to improper osteoporosis management.
What is the likelihood of acid-reflux rebound in a patient stopping a proton-pump inhibitor (PPI) (pantoprazole [Protonix]) after taking the medication for one month or more?
Clinicians should focus on increasing calcium intake among women who are not consuming enough of this mineral rather than increasing the calcium intake of those already consuming adequate amounts.
Use of supplemental calcium has increased greatly in recent years, yet Americans still may not be getting enough of this mineral.
Next post in Newsline